drugset / Trial / NCT03872128

The Role of Neuroactive Steroids in Stress, Alcohol Craving and Alcohol Use in Alcohol Use Disorders

NCT03872128

RandomizedParallel-groupQuadruple-blindTreatment

Summary

To use pregnenolone (PREG; 300; 500mg) daily versus placebo (PLA) as a probe to assess the role of neuroactive steroids in individuals with alcohol use disorder (AUD).

Timeline

Start
2018-09-27
Primary completion
2022-11-01
Completion
2023-08-01

Drugs

EvaluationDrugModalityDoseRoute
Comparator Pregnenolone Other / unclassified 300 mg
Comparator Pregnenolone Other / unclassified 500 mg